FMP
Aurinia Pharmaceuticals Inc.
AUP.TO
TSX
Inactive Equity
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
16.76 CAD
-0.6100006 (-3.64%)
About
ceo
Mr. Peter Greenleaf
sector
Healthcare
industry
Medical - Specialties
website
http://www.auriniapharma.com
exchange
TSX
Description
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
CIK
N/A
ISIN
N/A
CUSIP
N/A
Address
1203-4464 Markham St
Phone
12507084272
Country
CA
Employee
294
IPO Date
Sep 19, 2000
Summary
CIK
-
Exchange
TSX
Industry
Medical - Specialtie...
Sector
Healthcare
CUSIP
-
ISIN
-
Country
CA
Price
16.76
Beta
0.28
Volume Avg.
314.25k
Market Cap
0
Shares
-
52-Week
16.41-17.46
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-11.45
P/B
-
Website
http://www.auriniapharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest AUP.TO News
It looks like there's no news available.
